![]() To test the safety and effectiveness of drug-loaded nanoparticles for CVD prior to human studies, animal disease models are unavoidably needed. Nanoparticles have been studied recently for CVD due to their nanoscale size and unique properties, and hold a potential to be a novel therapy for the treatment. Tremendous progress has been made in the prevention and treatment of CVD however, there are still lots of limitations and new technology is needed. Cardiovascular disease (CVD) is the leading cause of mortality and morbidity worldwide.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |